Skip to main content

Table 2 The surgical details, adjuvant chemotherapy, and outcomes between laparoscopic and laparotomic groups

From: Laparoscopic versus laparotomic surgical treatment in apparent stage I ovarian cancer: a multi-center retrospective cohort study

 

Laparoscopic

(N = 16)

Laparotomic

(N = 21)

P—value

Surgical time (min)

213.5 ± 37.4

203.3 ± 51.0

0.507

Intraoperative blood loss (ml)*

231.3 ± 132.5

352.4 ± 156.9

0.018

Intraoperative transfusion

3 (18.8%)

3 (14.3%)

1.000

Number of LN sampling

18.6 ± 2.8

(N = 11)

17.5 ± 3.0

(N = 18)

0.359

 Pelvic LN

12.6 ± 4.0

11.9 ± 3.5

0.676

 Para-aortic LN

6.0 ± 1.8

5.6 ± 1.7

0.512

Intraoperative tumor rupture

1 (6.3%)

1 (4.8%)

1.000

Upstage

2 (12.5%)

4 (19.0%)

0.680

Postoperative complications

 ASGS grade 2

16 (100%)

21 (100%)

NS

 ASGS grade 3 or higher

-

-

 

Time to chemothearpy (d)*

7.4 ± 1.5

9.5 ± 2.7

0.004

Length of hospital stay (d)*

9.9 ± 1.6

13.8 ± 4.4

 < 0.001

  1. Abbreviations: LN lymph nodes, NS not significant, ASGS Accordion Severity Grading System
  2. *P < 0.05